Form 8-K - Current report:
SEC Accession No. 0001645113-24-000029
Filing Date
2024-09-03
Accepted
2024-09-03 07:00:17
Documents
15
Period of Report
2024-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20240830.htm   iXBRL 8-K 34355
2 EX-10.1 senioradvisoremploymentagr.htm EX-10.1 118400
3 EX-99.1 specialreportprsept2024.htm EX-99.1 13733
  Complete submission text file 0001645113-24-000029.txt   325249

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20240830.xsd EX-101.SCH 2001
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20240830_lab.xml EX-101.LAB 21801
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20240830_pre.xml EX-101.PRE 12579
17 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20240830_htm.xml XML 2707
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 241271872
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)